Leukemia Tissue Bank
Leukemia Tissue Bank
批准号:
7630234
负责人:
Sherif S Farag
金额:
$6.64万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AcuteAppointmentArtsAspirate substanceBasic ScienceBiologicalBloodBlood Component RemovalBlood specimenBone MarrowCancer and Leukemia Group BCentrifugationClinicalClinical DataClinical PathologyClinical ResearchClinical TrialsCollaborationsCollectionCommitConfidentialityConsentCountryCytogeneticsDNADataDatabasesDiagnosisDiagnosticDiseaseDoctor of MedicineDoctor of PhilosophyDrug KineticsEastern Cooperative Oncology GroupFreezingFundingGerm LinesGoalsGrowthHematologic NeoplasmsHematologistHeterogeneityHuman ResourcesInformed ConsentInstitutionLaboratoriesLeadershipLeftLymphomaMalignant NeoplasmsMedical OncologistMissionMolecularMolecular AnalysisMolecular CytogeneticsNatural HistoryNormal tissue morphologyNumbersOncology GroupOperative Surgical ProceduresOutcomePathologicPathologistPatientsPersonal SatisfactionPlasmaPlayPoliciesProceduresProcessPropertyProtocols documentationPublicationsQuality ControlRegulationResearchResearch Ethics CommitteesResearch InfrastructureResearch PersonnelResource SharingResourcesRetrievalRoleRoswell Park Cancer InstituteSamplingShippingShipsSolidSolid NeoplasmSourceSouthwest Oncology GroupSpecimenStandards of Weights and MeasuresSupport of ResearchSurgeonSwabThe Comprehensive Cancer Center Arthur G James Cancer Hospital and Richard J Solove Research Institute at Ohio State UniversityTimeTissue BanksTissue ProcurementsTissue SampleTissuesTrainingTranslatingTranslationsTumor BankWeekWorkloadbasechronic leukemiadaydensityexperiencefollow-upinterestleukemialeukemia/lymphomamemberoutcome forecastradiologistrepositoryresponsesample collectionstemsuccesstherapeutic targettissue resource
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The ability to successfully translate basic research in leukemia to the clinical setting, as well as to better
understand the relevance of observed clinical phenomena through laboratory-based research, is greatly
facilitated by the availability of an extensive repository of tissue samples, with accompanying complete
pathologic and clinical data, procured from leukemia patients. The OSUCCC Leukemia Tissue Bank
Shared Resource (LTBSR), separate and distinct from the CALGB Leukemia Tissue Bank, is a shared
resource established in 1997 with over 4,500 patient samples procured from 762 consented leukemia
patients at OSU. The infrastructure of the OSUCCC LTBSR is well-established and is directly under our
leadership. Specifically we have a large leukemia tissue repository, including both leukemic tissue and
normal tissue germ line DNA, accompanied in all cases with complete pathologic, cytogenetic and clinical
data for ready correlation of clinical and biological results. In addition, all the essentials of effective leukemia
tissue bank management, including the activities of tissue collection, quality control of specimens, tissue
storage, procurement of initial and follow-up samples and their pathology and clinical information, data entry
and database management, and patient consent and confidentiality are very well developed. Furthermore,
the procedures for prioritizing and distributing tissue to a large base of investigators within the OUCCC are
effectively in place. Finally, our success in managing this large leukemia tissue resource can be seen in the
documented sample collection for and sample distribution to all leukemia researchers within the CCC and 28
publications where the OSUCCC LTBSR has played a significant role. Against this background, we believe
that this Shared Resource will function well in the support of the research mission of the OSUCCC in
)roducing high-quality basic and clinical research in hematological malignancy. Currently the OSUCCC
_TBSR is funded solely with OSUCCC/institutional support. The Specific Aims of this Shared Resource are,
therefore, to: 1) Continue to provide a central collection, processing and a state-of-the-art repository for
samples collected from leukemia patients treated on OSU protocols, and 2) Provide materials from the
LTBSR to interested investigators within OSUCCC, as well as to outside interested investigators involved in
collaborative studies with OSU, who examine relevant cellular and molecular properties of leukemia.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Inhibition of PGE2 for mobilization of autologous peripheral blood stem cells
-
批准号:9261489
-
项目类别:
-
资助金额:$32.19万
-
财政年份:2014
-
负责人:Sherif S Farag
-
依托单位:
Inhibition of PGE2 for mobilization of autologous peripheral blood stem cells
-
批准号:8633799
-
项目类别:
-
资助金额:$34.95万
-
财政年份:2014
-
负责人:Sherif S Farag
-
依托单位:
Inhibition of PGE2 for mobilization of autologous peripheral blood stem cells
-
批准号:9052158
-
项目类别:
-
资助金额:$32.19万
-
财政年份:2014
-
负责人:Sherif S Farag
-
依托单位:
Multiple kinase target inhibition with EMND-2076 in multiple myeloma
-
批准号:8013948
-
项目类别:
-
资助金额:$31.0万
-
财政年份:2010
-
负责人:Sherif S Farag
-
依托单位:
Multiple kinase target inhibition with EMND-2076 in multiple myeloma
-
批准号:7787139
-
项目类别:
-
资助金额:$31.96万
-
财政年份:2010
-
负责人:Sherif S Farag
-
依托单位:
Pathology
-
批准号:6986013
-
项目类别:
-
资助金额:$20.85万
-
财政年份:2005
-
负责人:Sherif S Farag
-
依托单位:
Leukemia Tissue Bank
-
批准号:7613092
-
项目类别:
-
资助金额:$3.38万
-
财政年份:2005
-
负责人:Sherif S Farag
-
依托单位:
mTOR Inhibition as a Therapeutic Target in Myeloma
-
批准号:6940691
-
项目类别:
-
资助金额:$26.91万
-
财政年份:2004
-
负责人:Sherif S Farag
-
依托单位:
QMS Technology to Deplete T Cell Alloreactivity
-
批准号:6891062
-
项目类别:
-
资助金额:$59.94万
-
财政年份:2004
-
负责人:Sherif S Farag
-
依托单位:
mTOR Inhibition as a Therapeutic Target in Myeloma
-
批准号:6887130
-
项目类别:
-
资助金额:$26.91万
-
财政年份:2004
-
负责人:Sherif S Farag
-
依托单位:
QMS Technology to Deplete T Cell Alloreactivity
-
批准号:7242522
-
项目类别:
-
资助金额:$60.97万
-
财政年份:2004
-
负责人:Sherif S Farag
-
依托单位:
QMS Technology to Deplete T Cell Alloreactivity
-
批准号:7460784
-
项目类别:
-
资助金额:$58.86万
-
财政年份:2004
-
负责人:Sherif S Farag
-
依托单位:
QMS Technology to Deplete T Cell Alloreactivity
-
批准号:6778639
-
项目类别:
-
资助金额:$58.74万
-
财政年份:2004
-
负责人:Sherif S Farag
-
依托单位:
QMS Technology to Deplete T Cell Alloreactivity
-
批准号:7352036
-
项目类别:
-
资助金额:$59.58万
-
财政年份:2004
-
负责人:Sherif S Farag
-
依托单位:
NK Cell Recognition of Leukemia Blasts and IL-2 Therapy
-
批准号:6801432
-
项目类别:
-
资助金额:$26.61万
-
财政年份:2003
-
负责人:Sherif S Farag
-
依托单位:
NK Cell Recognition of Leukemia Blasts and IL-2 Therapy
-
批准号:6741595
-
项目类别:
-
资助金额:$26.61万
-
财政年份:2003
-
负责人:Sherif S Farag
-
依托单位:
Innate Immune Cell Therapy with Stem Cell Transplants
-
批准号:6653905
-
项目类别:
-
资助金额:$32.82万
-
财政年份:2002
-
负责人:Sherif S Farag
-
依托单位:
Innate Immune Cell Therapy with Stem Cell Transplants
-
批准号:6584712
-
项目类别:
-
资助金额:$32.82万
-
财政年份:2002
-
负责人:Sherif S Farag
-
依托单位:
Leukemia Tissue Bank
-
批准号:7630214
-
项目类别:
-
资助金额:$5.96万
-
财政年份:--
-
负责人:Sherif S Farag
-
依托单位:
Pathology
-
批准号:8117631
-
项目类别:
-
资助金额:$33.77万
-
财政年份:--
-
负责人:Sherif S Farag
-
依托单位:
海外基金